Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

Myriad Gentics, Inc.(MYGN)

 
123Jump Rating:   Underwriters: SG Cowen
      UBS Securities
Status:  
 
Address: 320 Wakara Way,
 FiledDate:
     
  Filed Price Range ($):
       
Telephone: (801) 584-3600 Filed Offer Amount ($ Million): $0.00
       
Fax: Shares Offered (Millions): 2,600,000
       
Websites: Shares Outstanding (Millions): 8,134,080
       
Management: Peter D. Meldrum, CEO
 IPO Date:
  Jay M. Moyes, VP-Finance
    
  John J. Horan, Chairman
 Final Offer Price ($): $0.00
       
Industry: Final Offer Size (Millions of Shares): 0.00
       
Employees: Final Offer Amount ($ Million): $0.00
       
Competitors: Eli Lily
 S-1 Forms:
  Bayer
    
   
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1992 0.00 0.00 0.00 0.00 -53.85 -.05
1993 550 1116 -566 0.00 -444.58 -.16
1994 600 4163 -3563 0.00 -3276.77 -.81
1995 1294.5 6950 -5655 0.00 -5268.38 -1.18
1996 6628.62 15517 -8888 0.00 -5897.47 -.82
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved